0001181431-14-002331.txt : 20140114 0001181431-14-002331.hdr.sgml : 20140114 20140114133459 ACCESSION NUMBER: 0001181431-14-002331 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140110 FILED AS OF DATE: 20140114 DATE AS OF CHANGE: 20140114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VICAL INC CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10390 PACIFIC CENTER COURT STREET 2: . CITY: SAN DIEGO STATE: CA ZIP: 92121-4340 BUSINESS PHONE: 858-646-1100 MAIL ADDRESS: STREET 1: 10390 PACIFIC CENTER COURT STREET 2: . CITY: SAN DIEGO STATE: CA ZIP: 92121-4340 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAMANT VIJAY B CENTRAL INDEX KEY: 0001198238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 14526719 MAIL ADDRESS: STREET 1: 9373 TOWNE CENTRE DRIVE SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121-3088 4 1 rrd399830.xml SAMANT JAN 2014 GRANT AND RSU RELEASE X0306 4 2014-01-10 0 0000819050 VICAL INC VICL 0001198238 SAMANT VIJAY B 10390 PACIFIC CENTER COURT SAN DIEGO CA 92121 1 1 0 0 President & CEO Common Stock $.01 par value 2014-01-10 4 P 0 330000 1.42 A 962211 D Common Stock $.01 par value 2014-01-11 4 F 0 2623 1.42 D 959588 D Common Stock $.01 par value 2014-01-11 4 F 0 7398 1.42 D 952190 D Common Stock $.01 par value 2014-01-13 4 F 0 1464 1.34 D 950726 D Nonstatutory Stock Option (right to buy) 1.42 2014-01-10 4 A 0 500000 0 A 2024-01-09 Common Stock 500000 2809000 D Shares were acquired pursuant to a restricted stock grant and generally vest one-third on the first anniversary of the grant, with the remainder vesting quarterly over the remaining two years. Represents shares withheld for taxes upon the release of restricted stock granted on January 11, 2010. Represents shares withheld for taxes upon the release of restricted stock granted on January 11, 2013. Represents shares withheld for taxes upon the release of restricted stock granted on January 13, 2012. This balance includes 464,450 of unvested restricted stock units. The right to exercise the above stock option is tied to performance-based objectives relating to the timing of patient enrollment and positive data release for the Company's Phase 1/2 HSV-2 clinical trial. Mr. Samant's salary remained unchanged at 2013 levels and he received no cash bonus. Sandy R. Medina (via Power of Attorney) 2014-01-14